Pneumococcal Vaccine for Adults Aged ≥19 Years: Recommendations of the Advisory Committee on Immunization Practices, United States, 2023
- PMID: 37669242
- PMCID: PMC10495181
- DOI: 10.15585/mmwr.rr7203a1
Pneumococcal Vaccine for Adults Aged ≥19 Years: Recommendations of the Advisory Committee on Immunization Practices, United States, 2023
Conflict of interest statement
All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. Katherine A. Poehling reports institutional support from Safe Sleep for All Newborns, Love Out Loud Early Childhood Fellow, Intimate Partner Violence Collaborative Project, Because You Matter: Conversations You Want about COVID-19, text messaging follow-up for patients who missed well-child visits, and Reimagining Health and Wellness by Mothers for Our Babies, Families, and Communities. No other potential conflicts of interest were disclosed.
Figures
Similar articles
-
Use of 21-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Recommendations of the Advisory Committee on Immunization Practices - United States, 2024.MMWR Morb Mortal Wkly Rep. 2024 Sep 12;73(36):793-798. doi: 10.15585/mmwr.mm7336a3. MMWR Morb Mortal Wkly Rep. 2024. PMID: 39264843 Free PMC article.
-
Use of 15-Valent Pneumococcal Conjugate Vaccine and 20-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Updated Recommendations of the Advisory Committee on Immunization Practices - United States, 2022.MMWR Morb Mortal Wkly Rep. 2022 Jan 28;71(4):109-117. doi: 10.15585/mmwr.mm7104a1. MMWR Morb Mortal Wkly Rep. 2022. PMID: 35085226 Free PMC article.
-
Prevention of pneumococcal disease among infants and children - use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine - recommendations of the Advisory Committee on Immunization Practices (ACIP).MMWR Recomm Rep. 2010 Dec 10;59(RR-11):1-18. MMWR Recomm Rep. 2010. PMID: 21150868
-
Recent Developments and Future Directions of Pneumococcal Vaccine Recommendations.Clin Ther. 2015 May 1;37(5):928-34. doi: 10.1016/j.clinthera.2015.03.025. Epub 2015 Apr 23. Clin Ther. 2015. PMID: 25913921 Review.
-
Immunogenicity following revaccination or sequential vaccination with 23-valent pneumococcal polysaccharide vaccine (PPSV23) in older adults and those at increased risk of pneumococcal disease: a review of the literature.Expert Rev Vaccines. 2021 Mar;20(3):257-267. doi: 10.1080/14760584.2021.1889374. Epub 2021 Mar 2. Expert Rev Vaccines. 2021. PMID: 33567914 Review.
Cited by
-
Cost-Effectiveness Analysis of the Use of V116, a 21-Valent Pneumococcal Conjugate Vaccine, in Vaccine-Naïve Adults Aged ≥ 65 Years in the United States.Infect Dis Ther. 2024 Dec;13(12):2597-2615. doi: 10.1007/s40121-024-01067-1. Epub 2024 Nov 8. Infect Dis Ther. 2024. PMID: 39514058 Free PMC article.
-
Brazilian Society of Otology task force - cochlear implant ‒ recommendations based on strength of evidence.Braz J Otorhinolaryngol. 2024 Sep 16;91(1):101512. doi: 10.1016/j.bjorl.2024.101512. Online ahead of print. Braz J Otorhinolaryngol. 2024. PMID: 39442262 Free PMC article. Review.
-
Protective Effects of 23-Valent Pneumococcal Polysaccharide Vaccination Against Mortality: The VENUS Study.Open Forum Infect Dis. 2024 Sep 11;11(9):ofae530. doi: 10.1093/ofid/ofae530. eCollection 2024 Sep. Open Forum Infect Dis. 2024. PMID: 39329110 Free PMC article.
-
Use of 21-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Recommendations of the Advisory Committee on Immunization Practices - United States, 2024.MMWR Morb Mortal Wkly Rep. 2024 Sep 12;73(36):793-798. doi: 10.15585/mmwr.mm7336a3. MMWR Morb Mortal Wkly Rep. 2024. PMID: 39264843 Free PMC article.
-
Infectious Disease Prophylaxis During and After Immunosuppressive Therapy.Kidney Int Rep. 2024 Apr 25;9(8):2337-2352. doi: 10.1016/j.ekir.2024.04.043. eCollection 2024 Aug. Kidney Int Rep. 2024. PMID: 39156157 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical